Logo image of ESF0.DE

EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

Europe - FRA:ESF0 - FR0014000MR3 - Common Stock

59.14 EUR
-0.68 (-1.14%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

6

ESF0 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ESF0 get a neutral evaluation. Nothing too spectacular is happening here. ESF0 scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make ESF0 suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ESF0 had positive earnings in the past year.
In the past year ESF0 had a positive cash flow from operations.
In the past 5 years ESF0 has always been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ESF0's Return On Assets of 3.54% is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
ESF0 has a Return On Equity of 8.09%. This is in the better half of the industry: ESF0 outperforms 61.11% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.79%, ESF0 belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 7.57%.
The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROIC 9.79%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 5.44%, ESF0 is doing worse than 61.11% of the companies in the same industry.
ESF0's Profit Margin has improved in the last couple of years.
The Operating Margin of ESF0 (15.59%) is comparable to the rest of the industry.
ESF0's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 23.29%, ESF0 is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
ESF0's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
Compared to 1 year ago, ESF0 has less shares outstanding
Compared to 5 years ago, ESF0 has more shares outstanding
The debt/assets ratio for ESF0 has been reduced compared to a year ago.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ESF0 has an Altman-Z score of 2.65. This is not the best score and indicates that ESF0 is in the grey zone with still only limited risk for bankruptcy at the moment.
ESF0 has a Altman-Z score (2.65) which is in line with its industry peers.
ESF0 has a debt to FCF ratio of 5.25. This is a neutral value as ESF0 would need 5.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.25, ESF0 is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
A Debt/Equity ratio of 0.77 indicates that ESF0 is somewhat dependend on debt financing.
ESF0 has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: ESF0 underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.25
Altman-Z 2.65
ROIC/WACC1.3
WACC7.52%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ESF0 (1.26) is comparable to the rest of the industry.
ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0 has a Quick ratio of 1.19. This is in the better half of the industry: ESF0 outperforms 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.50%, which is quite good.
The Earnings Per Share has been growing by 18.34% on average over the past years. This is quite good.
The Revenue has been growing slightly by 2.53% in the past year.
Measured over the past years, ESF0 shows a quite strong growth in Revenue. The Revenue has been growing by 8.78% on average per year.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%

3.2 Future

Based on estimates for the next years, ESF0 will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.34% on average per year.
ESF0 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.27% yearly.
EPS Next Y14.76%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
EPS Next 5Y13.34%
Revenue Next Year5.44%
Revenue Next 2Y5.6%
Revenue Next 3Y6.01%
Revenue Next 5Y7.27%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

ESF0 is valuated correctly with a Price/Earnings ratio of 16.43.
Compared to the rest of the industry, the Price/Earnings ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 88.89% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.67. ESF0 is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.65, which indicates a correct valuation of ESF0.
88.89% of the companies in the same industry are more expensive than ESF0, based on the Price/Forward Earnings ratio.
ESF0's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 31.86.
Industry RankSector Rank
PE 16.43
Fwd PE 14.65
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than ESF0, based on the Enterprise Value to EBITDA ratio.
94.44% of the companies in the same industry are more expensive than ESF0, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.74
EV/EBITDA 8.32
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ESF0 may justify a higher PE ratio.
A more expensive valuation may be justified as ESF0's earnings are expected to grow with 14.14% in the coming years.
PEG (NY)1.11
PEG (5Y)0.9
EPS Next 2Y14.31%
EPS Next 3Y14.14%

4

5. Dividend

5.1 Amount

ESF0 has a yearly dividend return of 0.99%, which is pretty low.
ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.72. ESF0 pays more dividend than 88.89% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, ESF0's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

54.91% of the earnings are spent on dividend by ESF0. This is a bit on the high side, but may be sustainable.
The dividend of ESF0 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (11/5/2025, 7:00:00 PM)

59.14

-0.68 (-1.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-21 2025-10-21
Earnings (Next)01-28 2026-01-28/amc
Inst Owners37.21%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.77B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts68.89
Price Target66.38 (12.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.33%
PT rev (3m)8.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.82%
Valuation
Industry RankSector Rank
PE 16.43
Fwd PE 14.65
P/S 1.56
P/FCF 13.74
P/OCF 8.19
P/B 2.32
P/tB N/A
EV/EBITDA 8.32
EPS(TTM)3.6
EY6.09%
EPS(NY)4.04
Fwd EY6.82%
FCF(TTM)4.3
FCFY7.28%
OCF(TTM)7.22
OCFY12.2%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.11
PEG (5Y)0.9
Graham Number45.4
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROCE 12.64%
ROIC 9.79%
ROICexc 10.74%
ROICexgc 34.1%
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
FCFM 11.37%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.25
Debt/EBITDA 2.1
Cap/Depr 84.94%
Cap/Sales 7.7%
Interest Coverage 9.93
Cash Conversion 77.37%
Profit Quality 209.21%
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 2.65
F-Score7
WACC7.52%
ROIC/WACC1.3
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.76%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
EPS Next 5Y13.34%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.44%
Revenue Next 2Y5.6%
Revenue Next 3Y6.01%
Revenue Next 5Y7.27%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year86.11%
EBIT Next 3Y30.34%
EBIT Next 5Y22%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

Can you provide the ChartMill fundamental rating for EUROFINS SCIENTIFIC?

ChartMill assigns a fundamental rating of 6 / 10 to ESF0.DE.


Can you provide the valuation status for EUROFINS SCIENTIFIC?

ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Undervalued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for ESF0 stock?

The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ESF0.DE) is expected to grow by 14.76% in the next year.


Can you provide the dividend sustainability for ESF0 stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.91%.